Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability